RhumbLine Advisers’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.2M | Sell |
|
|||||
|
2025
Q2 | $12.9M | Buy |
|
|||||
|
2025
Q1 | $15M | Sell |
|
|||||
|
2024
Q4 | $18.1M | Buy |
|
|||||
|
2024
Q3 | $20M | Sell |
|
|||||
|
2024
Q2 | $20.5M | Buy |
|
|||||
|
2024
Q1 | $21.5M | Buy |
|
|||||
|
2023
Q4 | $23.5M | Buy |
|
|||||
|
2023
Q3 | $8.1M | Buy |
|
|||||
|
2023
Q2 | $8.87M | Buy |
|
|||||
|
2023
Q1 | $9.12M | Buy |
|
|||||
|
2022
Q4 | $11.3M | Buy |
|
|||||
|
2022
Q3 | $11.6M | Buy |
|
|||||
|
2022
Q2 | $8.56M | Buy |
|
|||||
|
2022
Q1 | $7.44M | Buy |
|
|||||
|
2021
Q4 | $8.55M | Buy |
|
|||||
|
2021
Q3 | $6.68M | Sell |
|
|||||
|
2021
Q2 | $3.87M | Sell |
|
|||||
|
2021
Q1 | $4.73M | Buy |
|
|||||
|
2020
Q4 | $4.13M | Buy |
|
|||||
|
2020
Q3 | $4.04M | Buy |
|
|||||
|
2020
Q2 | $4.11M | Sell |
|
|||||
|
2020
Q1 | $2.13M | Buy |
|
|||||
|
2019
Q4 | $1.88M | Buy |
|
|||||
|
2019
Q3 | $1.89M | Buy |
|
|||||
|
2019
Q2 | $1.81M | Buy |
|
|||||
|
2019
Q1 | $1.19M | Sell |
|
|||||
|
2018
Q4 | $936K | Buy |
|
|||||
|
2018
Q3 | $1.22M | Buy |
|
|||||
|
2018
Q2 | $995K | Buy |
|
|||||
|
2018
Q1 | $791K | Buy |
|
|||||
|
2017
Q4 | $860K | Buy |
|
|||||
|
2017
Q3 | $1.28M | Buy |
|
|||||
|
2017
Q2 | $999K | Buy |
|
|||||
|
2017
Q1 | $503K | Buy |
|
|||||
|
2016
Q4 | $462K | Buy |
|
|||||
|
2016
Q3 | $320K | Sell |
|
|||||
|
2016
Q2 | $386K | Sell |
|
|||||
|
2016
Q1 | $305K | Buy |
|
|||||
|
2015
Q4 | $425K | Buy |
|
|||||
|
2015
Q3 | $267K | Buy |
|
|||||
|
2015
Q2 | $256K | Sell |
|
|||||
|
2015
Q1 | $316K | Buy |
|
|||||
|
2014
Q4 | $363K | Buy |
|
|||||
|
2014
Q3 | $145K | Hold |
|
|||||
|
2014
Q2 | $197K | Buy |
|
|||||
|
2014
Q1 | $145K | Buy |
|
|||||
|
2013
Q4 | $74K | Buy |
|
|||||
|
2013
Q3 | $78K | Sell |
|
|||||
|
2013
Q2 | $121K | Buy |
|